Cite
HARVARD Citation
Wallace, D. et al. (n.d.). Long‐Term Safety and Efficacy of Epratuzumab in the Treatment of Moderate‐to‐ Severe Systemic Lupus Erythematosus: Results From an Open‐Label Extension Study. Arthritis care & research. 68 (4), pp. 534-543. [Online].